Address
Prospect Venture Partners
435 Tasso Street
Suite 200
Palo Alto, CA 94301
United States
Phone
Website
Recent investment activity
KANDO id: 28604
Corporate information
Registration country
Company type
Venture capital firmFunds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Prospect Venture Partners III LP | Venture | 2005 | USD | 500,000,000 |
| Prospect Venture Partners II LP | Venture | 2001 | USD | 500,000,000 |
| Prospect Venture Partners I LP | Venture | 1997 | USD | 100,000,000 |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 48| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Amira Pharmaceuticals Inc | A small molecule pharmaceutical company focused on the discovery and early development of compounds. | N/A | |||
|
|
Archemix Corp | A biotechnology company, engages in discovering, developing, and commercializing aptamer therapeutics for the treatment of life threatening diseases. | N/A | |||
|
|
Aspen Medtech Inc | Medical device incubator. | N/A | |||
|
|
Azelon Pharmaceuticals Inc | Series A | ||||
|
|
Cogentus Pharmaceuticals Inc | Series C | ||||
|
|
Critical Therapeutics Inc | Discoverer, developer and commercialize novel therapies. | N/A | |||
|
|
DFINE Inc | Mission is to develop and market devices that treat vertebral compression | N/A | |||
|
|
Gloucester Pharmaceuticals Inc | N/A | ||||
|
|
IDUN Pharmaceuticals Inc | N/A | ||||
|
|
Infinity Pharmaceuticals Inc | Innovative drug discovery and development company. | N/A | |||
|
|
Inhibitex Inc | N/A | ||||
|
Jazz Pharmaceuticals Inc | N/A | ||||
|
|
KYTHERA Biopharmaceuticals Inc | Series D | ||||
|
|
KYTHERA Biopharmaceuticals Inc | Series C | ||||
|
|
Lux Biosciences Inc | Clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases. | N/A | |||
|
|
NGM Biopharmaceuticals Inc | Biopharmaceutical company focused on the discovery and development of breakthrough therapeutics for metabolic diseases. | N/A | |||
|
|
NinePoint Medical Inc | A transformational medical device company, develops in vivo pathology medical devices. | N/A | |||
|
|
Nora Therapeutics Inc | Specialty biopharmaceutical company that focuses on developing therapeutics to address clinical unmet needs in reproductive medicine. | N/A | |||
|
|
Novacept Inc | Commercializing innovative medical devices to improve the quality and cost-effectiveness of healthcare for women. | N/A | |||
|
|
Opus Medical Inc | Minimally invasive techniques for orthopedic surgery. | N/A | |||
|
|
Panmira Pharmaceuticals LLC | Pharmaceutical company for inflammatory diseases. | N/A | |||
|
|
Pathwork Diagnostics Inc | N/A | ||||
|
|
Phylogix Inc | Biotechnology company focused on tissue protection and oncology. | Series B | |||
|
|
Roxro Pharma Inc | Develops drugs for pain treatment | Series B | |||
|
|
Somaxon Pharmaceuticals Inc | N/A |